Kyle J. MacBeth
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 30
- Acute Myeloid Leukemia Research 28
- Multiple Myeloma Research and Treatments 5
- Genetics 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Co-authors
- Carla C. Heise (4 shared papers)Aaron Ngocky Nguyen (3 shared papers)Tao Shi (5 shared papers)Hagop Kantarjian (4 shared papers)Steven D. Gore (9 shared papers)Christopher Ramin Cogle (8 shared papers)Eric J. Laille (8 shared papers)Guillermo Garcia‐Manero (8 shared papers)
- Journals
- Blood (12 papers)Leukemia (5 papers)Journal of Experimental Zoology (2 papers)Journal of Clinical Oncology (2 papers)Nature Medicine (2 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Kyle J. MacBeth
47 papers receiving 3.5k citations
Kyle J. MacBeth's Hit Papers
Peers
Comparison fields: 5 of 91
- Hematology 2.2k
- Genetics 588
- Molecular Biology 1.9k
- Cancer Research 298
- Oncology 542
Countries citing papers authored by Kyle J. MacBeth
This map shows the geographic impact of Kyle J. MacBeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle J. MacBeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle J. MacBeth more than expected).
Fields of papers citing papers by Kyle J. MacBeth
This network shows the impact of papers produced by Kyle J. MacBeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle J. MacBeth. The network helps show where Kyle J. MacBeth may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle J. MacBeth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS Hit paper breakdown → | 2015 | 733 |
| 2 | 2010 | 314 | |
| 3 | 2018 | 269 | |
| 4 | 2011 | 223 | |
| 5 | 2016 | 191 | |
| 6 | 2019 | 187 | |
| 7 | 2018 | 173 | |
| 8 | 2018 | 158 | |
| 9 | 2020 | 156 | |
| 10 | 2014 | 119 | |
| 11 | 2018 | 113 | |
| 12 | 2015 | 101 | |
| 13 | 2020 | 91 | |
| 14 | 2021 | 90 | |
| 15 | 2016 | 71 | |
| 16 | 2007 | 62 | |
| 17 | 2015 | 56 | |
| 18 | 2019 | 54 | |
| 19 | 2010 | 47 | |
| 20 | 2018 | 47 |
About Kyle J. MacBeth
Kyle J. MacBeth is a scholar working on Hematology, Genetics, Infectious Diseases, Molecular Biology and Cancer Research, having authored 47 papers that have together received 3.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Protein Degradation and Inhibitors (8 papers), Histone Deacetylase Inhibitors Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), HIV/AIDS drug development and treatment (5 papers), Research on Leishmaniasis Studies (5 papers), Epigenetics and DNA Methylation (5 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (588 citations), Molecular Biology (1.9k citations), Cancer Research (298 citations) and Oncology (542 citations). Kyle J. MacBeth has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Carla C. Heise, Aaron Ngocky Nguyen, Tao Shi, Hagop Kantarjian, Steven D. Gore, Christopher Ramin Cogle, Eric J. Laille, Guillermo Garcia‐Manero, Barry Skikne and Yuhong Ning. Their work appears in journals such as Blood, Leukemia, Journal of Experimental Zoology, Journal of Clinical Oncology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.